[ Price : $8.95]
Two FDA advisory committees are considering whether including an antagonist in an extended-release morphine capsule is sufficient ...[ Price : $8.95]
CDER and CBER issue a question-and-answer guidance on production and process controls.[ Price : $8.95]
Federal Register Notice: FDA sends a proposed collection of information on CGMPs for blood and blood components and requirements f...[ Price : $8.95]
Federal Register Proposed rule: FDA plans to amend its regulations to adjust the maximum civil money penalty amounts for inflation...[ Price : $8.95]
FDAs Philadelphia District Office warns Power Medical Interventions over quality and medical device reporting violations at its ma...[ Price : $8.95]
FDA approves a 30-minute onset of action labeling claim for Novartis ADHD drug Focalin XR extended-release capsules.[ Price : $8.95]
Obama transition team members are heading into federal agencies amid anonymous comments suggesting a major shake-up to rid FDA of ...[ Price : $8.95]
Federal Register Notice: FDA approves a First Priority ANADA for veterinary prescription use of phenylbutazone tablets in horses.